drugset / Trial / NCT03864432
An Ascending Dose, Single/Multiple Dosing, Food Effect Clinical Trial to Evaluate Pharmacokinetics, Safety and Tolerability in Healthy Subjects After Oral Administration of Gemigliptin (Phase I)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To determine the pharmacokinetic properties, safety and tolerability of single/multiple oral administration of Gemigliptin and Food effect in healthy Chinese subjects.
Timeline
- Start
- 2019-07-02
- Primary completion
- 2019-10-03
- Completion
- 2020-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemigliptin | Small molecule | 25 mg | Oral |
| Subject | Gemigliptin | Small molecule | 50 mg | Oral |
| Subject | Gemigliptin | Small molecule | 100 mg | Oral |